Ilae Treatment Guidelines: Evidence-based Analysis Of Antiepileptic Drug Efficacy And Effectiveness As Initial Monotherapy For Epileptic Seizures And Syndromes

dc.creatorGlauser T.
dc.creatorBen-Menachem E.
dc.creatorBourgeois B.
dc.creatorCnaan A.
dc.creatorChadwick D.
dc.creatorGuerreiro C.
dc.creatorKalviainen R.
dc.creatorMattson R.
dc.creatorPerucca E.
dc.creatorTomson T.
dc.date2006
dc.date2015-06-30T18:13:34Z
dc.date2015-11-26T14:27:43Z
dc.date2015-06-30T18:13:34Z
dc.date2015-11-26T14:27:43Z
dc.date.accessioned2018-03-28T21:30:51Z
dc.date.available2018-03-28T21:30:51Z
dc.identifier
dc.identifierEpilepsia. , v. 47, n. 7, p. 1094 - 1120, 2006.
dc.identifier139580
dc.identifier10.1111/j.1528-1167.2006.00585.x
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-33746124186&partnerID=40&md5=b3f70064ac33a5338721463653342ef7
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/103572
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/103572
dc.identifier2-s2.0-33746124186
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1246405
dc.descriptionPurpose: To assess which antiepileptic medications (AEDs) have the best evidence for long-term efficacy or effectiveness as initial monotherapy for patients with newly diagnosed or untreated epilepsy. Methods: A 10-member subcommission of the Commission on Therapeutic Strategies of The International League Against Epilepsy (ILAE), including adult and pediatric epileptologists, clinical pharmacologists, clinical trialists, and a statistician evaluated available evidence found through a structured literature review including MEDLINE, Current Contents and the Cochrane Library for all applicable articles from 1940 until July 2005. Articles dealing with different seizure types (for different age groups) and two epilepsy syndromes were assessed for quality of evidence (four classes) based on predefined criteria. Criteria for class I classification were a double-blind randomized controlled trial (RCT) design, ≥48-week treatment duration without forced exit criteria, information on ≥24-week seizure freedom data (efficacy) or ≥48-week retention data (effectiveness), demonstration of superiority or 80% power to detect a ≤20% relative difference in efficacy/effectiveness versus an adequate comparator, and appropriate statistical analysis. Class II studies met all class I criteria except for having either treatment duration of 24 to 47 weeks or, for noninferiority analysis, a power to only exclude a 21-30% relative difference. Class III studies included other randomized double-blind and open-label trials, and class IV included other forms of evidence (e.g., expert opinion, case reports). Quality of clinical trial evidence was used to determine the strength of the level of recommendation. Results: A total of 50 RCTs and seven meta-analyses contributed to the analysis. Only four RCTs had class I evidence, whereas two had class II evidence; the remainder were evaluated as class III evidence. Three seizure types had AEDs with level A or level B efficacy and effectiveness evidence as initial monotherapy: adults with partial-onset seizures (level A, carbamazepine and phenytoin; level B, valproic acid), children with partial-onset seizures (level A, oxcarbazepine; level B, None), and elderly adults with partial-onset seizures (level A, gabapentin and lamotrigine; level B, None). One adult seizure type [adults with generalized-onset tonic-clonic (GTC) seizures], two pediatric seizure types (GTC seizures and absence seizures), and two epilepsy syndromes (benign epilepsy with centrotemporal spikes and juvenile myoclonic epilepsy) had no AEDs with level A or level B efficacy and effectiveness evidence as initial monotherapy. Conclusions: This evidence-based guideline focused on AED efficacy or effectiveness as initial monotherapy for patients with newly diagnosed or untreated epilepsy. The absence of rigorous comprehensive adverse effects data makes it impossible to develop an evidence-based guideline aimed at identifying the overall optimal recommended initial-monotherapy AED. There is an especially alarming lack of well-designed, properly conducted RCTs for patients with generalized seizures/epilepsies and for children in general. The majority of relevant existing RCTs have significant methodologic problems that limit their applicability to this guideline's clinically relevant main question. Multicenter, multinational efforts are needed to design, conduct and analyze future clinically relevant RCTs that can answer the many outstanding questions identified in this guideline. The ultimate choice of an AED for any individual patient with newly diagnosed or untreated epilepsy should include consideration of the strength of the efficacy and effectiveness evidence for each AED along with other variables such as the AED safety and tolerability profile, pharmacokinetic properties, formulations, and expense. When selecting a patient's AED, physicians and patients should consider all relevant variables and not just efficacy and effectiveness. © 2006 International League Against Epilepsy.
dc.description47
dc.description7
dc.description1094
dc.description1120
dc.descriptionDefinition of key terms (1990) Clinical Practice Guidelines: Directions for a New Program, pp. 33-51. , Field MJ, Lohr KN, eds. Washington, DC: National Academy Press
dc.descriptionProposal for revised clinical and electroencephalographic classification of epileptic seizures (1981) Epilepsia, 22, pp. 489-501
dc.descriptionProposal for revised classification of epilepsies and epileptic syndromes (1989) Epilepsia, 30, pp. 389-399
dc.descriptionConsiderations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy (1998) Epilepsia, 39, pp. 799-803
dc.descriptionChadwick, D., Monotherapy clinical trials of new antiepileptic drugs: Design, indications, and controversies (1997) Epilepsia, 38 (9 SUPPL.), pp. S16-20
dc.descriptionSchulz, K.F., Chalmers, I., Hayes, R.J., Altman, D.G., Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995) JAMA, 273, pp. 408-412
dc.descriptionSchulz, K.F., Grimes, D.A., Allocation concealment in randomised trials: Defending against deciphering (2002) Lancet, 359, pp. 614-618
dc.descriptionSchulz, K.F., Grimes, D.A., Blinding in randomised trials: Hiding who got what (2002) Lancet, 359, pp. 696-700
dc.descriptionChadwick, D., Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised DB study: Vigabatrin European Monotherapy Study Group (1999) Lancet, 354, pp. 13-19
dc.descriptionChan, I.S., Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies (1998) Stat Med, 17, pp. 1403-1413
dc.description(2003) Version 6 with Cytel StudioTM Statistical Software for Exact Nonparametric Inference, , Cambridge, Mass: CYTEL Software Corporation
dc.descriptionAcute pain management: Operative or medical procedures and trauma (1993) Clinical Practice Guideline No. 1, p. 107. , Agency for Healthcare Policy and Research Research, Rockville, Md: Agency for Healthcare Policy and Research
dc.descriptionEdlund, W., Gronseth, G., So, Y., Franklin, G., (2004) American Academy of Neurology Clincal Practice Guideline Process Manual, , St. Paul, Minn.: American Academy of Neurology
dc.descriptionFrench, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new onset epilepsy: Report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society (2004) Neurology, 62, pp. 1252-1260
dc.descriptionFrench, J.A., Kanner, A.M., Bautista, J., Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society (2004) Epilepsia, 45, pp. 401-409
dc.descriptionConsensus statements: Medical management of epilepsy (1998) Neurology, 51 (5 SUPPL. 4), pp. S39-43
dc.descriptionRoss, S.D., Estok, R., Chopra, S., French, J., Management of newly diagnosed patients with epilepsy: A systematic review of the literature (2001) Evid Rep Technol Assess (Summ), 39, pp. 1-3
dc.descriptionArmijo, J.A., Sanchez, B., Gonzalez, A.B., Evidence based treatment of epilepsy (2002) Rev Neurol, 35 (1 SUPPL.), pp. S59-73
dc.descriptionRamsay, R.E., DeToledo, J., Tonic-clonic seizures: A systematic review of antiepilepsy drug efficacy and safety (1997) Clin Ther, 19, pp. 433-446
dc.descriptionPosner, E.B., Mohamed, K., Marson, A.G., A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine (2005) Seizure, 14, pp. 1179-1222
dc.descriptionPractice parameter: Management issues for women with epilepsy (1998) Epilepsia, 39, pp. 1226-1231
dc.descriptionPractice parameter: Management issues for women with epilepsy (1998) Neurology, 51, pp. 944-948
dc.descriptionClinical guidelines for the management of epilepsy in adults with an intellectual disability (2001) Seizure, 10, pp. 401-409
dc.descriptionCamfield, P., Camfield, C., Childhood epilepsy: What is the evidence for what we think and what we do? (2003) J Child Neurol, 18, pp. 272-287
dc.descriptionGram, L., Bentsen, K.D., Parnas, J., Controlled trials in epilepsy: A review (1982) Epilepsia, 23, pp. 491-519
dc.descriptionCochrane, H.C., Marson, A.G., Baker, G.A., Chadwick, D.W., Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards (1998) Epilepsia, 39, pp. 1088-1097
dc.descriptionBrunbech, L., Sabers, A., Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: A comparative review of newer versus older agents (2002) Drugs, 62, pp. 593-604
dc.descriptionBaker, G.A., Hesdon, B., Marson, A.G., Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards (2000) Epilepsia, 41, pp. 1357-1363
dc.descriptionKotsopoulos, I.A., Evers, S.M., Ament, A.J., De Krom, M.C., Estimating the costs of epilepsy: An international comparison of epilepsy cost studies (2001) Epilepsia, 42, pp. 634-640
dc.descriptionLevy, P., Economic evaluation of antiepileptic drug therapy: A methodologic review (2002) Epilepsia, 43, pp. 550-558
dc.descriptionMattson, R.H., Cramer, J.A., Collins, J.F., Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures (1985) N Engl J Med, 313, pp. 145-151
dc.descriptionTurnbull, D.M., Howel, D., Rawlins, M.D., Chadwick, D.W., Which drug for the adult epileptic patient: Phenytoin or valproate? (1985) Br Med J (Clin Res Ed), 290, pp. 815-819
dc.descriptionDam, M., Ekberg, R., Loyning, Y., A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy (1989) J Neurol Neurosurg Psychiatry, 52, pp. 472-476
dc.descriptionMattson, R.H., Cramer, J.A., Collins, J.F., A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults: The Department of Veterans Affair's Epilepsy Cooperative Study No. 264 Group (1992) N Engl J Med, 327, pp. 765-771
dc.descriptionRichens, A., Davidson, D.L., Cartridge, N.E., Easter, D.J., A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy: Adult EPITEG Collaborative Group (1994) J Neurol Neurosurg Psychiatry, 57, pp. 682-687
dc.descriptionHeller, A.J., Chesterman, P., Elwes, R.D., Phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed adult epilepsy: A randomised comparative monotherapy trial (1995) J Neurol Neurosurg Psychiatry, 58, pp. 44-50
dc.descriptionBrodie, M., Richens, A., Yuen, A.W., Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy: UK Lamotrigine/Carbamazepine Monotherapy Trial Group (1995) Lancet, 345, pp. 476-479
dc.descriptionBill, P.A., Vigonius, U., Pohlmann, H., A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy (1997) Epilepsy Res, 27, pp. 195-204
dc.descriptionChriste, W., Kramer, G., Vigonius, U., A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy (1997) Epilepsy Res, 26, pp. 451-460
dc.descriptionChadwick, D.W., Anhut, H., Greiner, M.J., A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures: International Gabapentin Monotherapy Study Group 945-77 (1998) Neurology, 51, pp. 1282-1288
dc.descriptionSteiner, T.J., Dellaportas, C.I., Findley, L.J., Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin (1999) Epilepsia, 40, pp. 601-607
dc.descriptionGilliam, F.G., Veloso, F., Bomhof, M.A., A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy (2003) Neurology, 60, pp. 196-202
dc.descriptionPrivitera, M.D., Brodie, M.J., Mattson, R.H., Topiramate, carbamazepine and valproate monotherapy: Double-blind comparison in newly diagnosed epilepsy (2003) Acta Neurol Scand, 107, pp. 165-175
dc.descriptionArroyo, S., Dodson, W.E., Privitera, M.D., A Randomized dose-controlled study of topiramate as first-line therapy in epilepsy (2005) Acta Neurol Scand, 112, pp. 214-222
dc.description(2004) Trileptal Prescribing Information, , East Hanover, New Jersey
dc.descriptionNieto-Barrera, M., Brozmanova, M., Capovilla, G., A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy (2001) Epilepsy Res, 46, pp. 145-155
dc.descriptionMikkelsen, B., Berggreen, P., Joensen, P., Clonazepam (Rivotril) and carbamazepine (Tegretol) in psychomotor epilepsy: A randomized multicenter trial (1981) Epilepsia, 22, pp. 415-420
dc.descriptionRamsay, R.E., Wilder, B.J., Berger, J.R., Bruni, J., A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults (1983) Neurology, 33, pp. 904-910
dc.descriptionBrodie, M.J., Chadwick, D.W., Anhut, H., Gabapentin versus lamotrigine monotherapy: A double-blind comparison in newly diagnosed epilepsy (2002) Epilepsia, 43, pp. 993-1000
dc.descriptionCallaghan, N., Kenny, R.A., O'Neill, B., A prospective study between carbamazepine, phenytoin, and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy (1985) J Neurol Neurosurg Psychiatry, 48, pp. 639-644
dc.descriptionReunanen, M., Dam, M., Yuen, A.W., A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy (1996) Epilepsy Res, 23, pp. 149-155
dc.descriptionLoiseau, P., Cohadon, S., Jogeix, M., Efficacy of sodium valproate in partial epilepsy: Crossed study of valproate and carbamazepine (1984) Rev Neurol (Paris), 140, pp. 434-437
dc.descriptionTurnbull, D.M., Rawlins, M.D., Weightman, D., Chadwick, D.W., A comparison of phenytoin and valproate in previously untreated adult epileptic patients (1982) J Neurol Neurosurg Psychiatry, 45, pp. 55-59
dc.descriptionPlacencia, M., Sander, J.W., Shorvon, S.D., Antiepileptic drug treatment in a community health care setting in northern Ecuador: A prospective 12-month assessment (1993) Epilepsy Res, 14, pp. 237-244
dc.descriptionKalviainen, R., Aikia, M., Saukkonen, A.M., Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy: A randomized, controlled study (1995) Arch Neurol, 52, pp. 989-996
dc.descriptionGibberd, F.B., Park, D.M., Scott, G., A comparison of phenytoin and pheneturide in patients with epilepsy: A double-blind cross-over trial (1982) J Neurol Neurosurg Psychiatry, 45, pp. 1113-1118
dc.descriptionSommerfeld-Ziskin, The effect of phenobarbital on the mentality of epileptic patients (1940) Arch Neurol Psychiatry, 43, pp. 70-79
dc.descriptionFeksi, A.T., Kaamugisha, J., Gatiti, S., Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya: ICBERG (International Community-based Epilepsy Research Group) (1991) Lancet, 337, pp. 406-409
dc.descriptionShakir, R.A., Johnson, R.H., Lambie, D.G., Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy (1981) Epilepsia, 22, pp. 27-33
dc.descriptionRastogi, P., Mehrotra, T.N., Agarwala, R.K., Singh, V.S., Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy (1991) J Assoc Physicians India, 39, pp. 606-608
dc.descriptionTanganelli, P., Regesta, G., Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: A randomized response conditional cross-over study (1996) Epilepsy Res, 25, pp. 257-262
dc.descriptionPrevey, M.L., Delaney, R.C., Cramer, J.A., Effect of valproate on cognitive functioning: Comparison with carbamazepine: The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group (1996) Arch Neurol, 53, pp. 1008-1016
dc.descriptionPulliainen, V., Jokelainen, M., Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients (1994) Acta Neurol Scand, 89, pp. 81-86
dc.descriptionPulliainen, V., Jokelainen, M., Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: A two-year follow-up (1995) Epilepsia, 36, pp. 1195-1202
dc.descriptionAikia, M., Kalviaïnen, R., Sivenius, J., Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow-up (1992) Epilepsy Res, 11, pp. 199-203
dc.descriptionBrodie, M.J., Wroe, S.J., Dean, A.D., Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: Comparison by sequential analysis (2002) Epilepsy Behav, 3, pp. 140-146
dc.descriptionMarson, A.G., Williamson, P.R., Clough, H., Carbamazepine versus valproate monotherapy for epilepsy: A meta-analysis (2002) Epilepsia, 43, pp. 505-513
dc.descriptionTudur Smith, C., Marson, A.G., Clough, H.E., Williamson, P.R., Carbamazepine versus phenytoin monotherapy for epilepsy (2002) Cochrane Database Syst Rev, pp. CD001911
dc.descriptionTudur Smith, C., Marson, A.G., Williamson, P.R., Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (2001) Cochrane Database Syst Rev, pp. CD001769
dc.descriptionTaylor, S., Tudur Smith, C., Williamson, P.R., Marson, A.G., Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (2001) Cochrane Database Syst Rev, pp. CD002217
dc.descriptionTudur Smith, C., Marson, A.G., Williamson, P.R., Carbamazepine versus phenobarbitone monotherapy for epilepsy (2003) Cochrane Database Syst Rev, pp. CD001904
dc.descriptionWhitehead, J., Stevens, J., Brodie, M., Remacemide versus carbamazepine in newly diagnosed epilepsy (2002) Epilepsy Beh, 3, pp. 405-406
dc.descriptionVerity, C.M., Hosking, G., Easter, D.J., A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy: The Paediatric EPITEG Collaborative Group (1995) Dev Med Child Neurol, 37, pp. 97-108
dc.descriptionDe Silva, M., MacArdle, B., McGowan, M., Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy (1996) Lancet, 347, pp. 709-713
dc.descriptionGuerreiro, M.M., Vigonius, U., Pohlmann, H., A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy (1997) Epilepsy Res, 27, pp. 205-213
dc.descriptionClobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy: Canadian Study Group for Childhood Epilepsy (1998) Epilepsia, 39, pp. 952-959
dc.descriptionPal, D.K., Das, T., Chaudhury, G., Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India (1998) Lancet, 351, pp. 19-23
dc.descriptionWheless, J.W., Neto, W., Wang, S., Topiramate, carbamazepine, and valproate monotherapy: Double-blind comparison in children with newly diagnosed epilepsy (2004) J Child Neurol, 19, pp. 135-141
dc.descriptionZamponi, N., Cardinali, C., Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children (1999) Arch Neurol, 56, pp. 605-607
dc.descriptionDodson, W.E., Carbamazepine efficacy and utilization in children (1987) Epilepsia, 28 (3 SUPPL.), pp. S17-24
dc.descriptionYoung, R.S., Alger, P.M., Bauer, L., Lauderbaugh, D., A randomized, double-blind, crossover study of phenobarbital and mephobarbital (1986) J Child Neurol, 1, pp. 361-363
dc.descriptionMitchell, W.G., Chavez, J.M., Carbamazepine versus phenobarbital for partial onset seizures in children (1987) Epilepsia, 28, pp. 56-60
dc.descriptionNolte, R.W., Brugmann, B., Britzinger, G., Effects of phenytoin- and primidone-induced monotherapy on mental performance in children, in antiepileptic therapy (1980) Advances in Drug Monitoring, , Johannssen SI, ed. New York: Raven Press
dc.descriptionChen, Y.J., Kang, W.M., So, W.C., Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: A psychometric and neurophysiological study (1996) Epilepsia, 37, pp. 81-86
dc.descriptionForsythe, I., Butler, R., Berg, I., McGuire, R., Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate (1991) Dev Med Child Neurol, 33, pp. 524-534
dc.descriptionBerg, I., Butler, A., Ellis, M., Foster, J., Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: A random trial (1993) Dev Med Child Neurol, 35, pp. 149-157
dc.descriptionGlauser, T.A., Dlugos, D.J., Dodson, W.E., A Double-blind Dose-controlled Study Evaluated Topiramate As Monotherapy in 470 Patients with Newly Diagnosed (≤3 Months) Epilepsy or Epilepsy Relapse in the Absence of Therapy, , in press
dc.descriptionRowan, A.J., Ramsay, R.E., Collins, J.F., New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine (2005) Neurology, 64, pp. 1868-1873
dc.descriptionBrodie, M.J., Overstall, P.W., Giorgi, L., Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy: The UK Lamotrigine Elderly Study Group (1999) Epilepsy Res, 37, pp. 81-87
dc.descriptionCraig, I., Tallis, R., Impact of valproate and phenytoin on cognitive function in elderly patients: Results of a single-blind randomized comparative study (1994) Epilepsia, 35, pp. 381-390
dc.descriptionRamsay, R.E.W., Murphy, B.J., Holmes, J.V., Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures (1992) J Epilepsy, 5, pp. 55-60
dc.descriptionPerucca, E., Gram, L., Avanzini, G., Dulac, O., Antiepileptic drugs as a cause of worsening seizures (1998) Epilepsia, 39, pp. 5-17
dc.descriptionShields, W., Saslow, E., Myoclonic, atonic and absence seizures following institution of carbamazepine therapy in children (1983) Neurology, 33, pp. 1487-1489
dc.descriptionGuerrini, R., Belmonte, A., Genton, P., Antiepileptic drug-induced worsening of seizures in children (1998) Epilepsia, 39 (3 SUPPL.), pp. S2-10
dc.descriptionGenton, P., When antiepileptic drugs aggravate epilepsy (2000) Brain Dev, 22, pp. 75-80
dc.descriptionThilothammal, N., Banu, K., Ratnam, R.S., Comparison of phenobarbitone, phenytoin with sodium valproate: Randomized, double-blind study (1996) Indian Pediatr, 33, pp. 549-555
dc.descriptionTrudeau, V., Myers, S., LaMoreaux, L., Gabapentin in naive childhood absence epilepsy: Results from two double-blind, placebo-controlled, multicenter studies (1996) J Child Neurol, 11, pp. 470-475
dc.descriptionFrank, L.M., Enlow, T., Holmes, G.L., Lamictal (lamotrigine) monotherapy for typical absence seizures in children (1999) Epilepsia, 40, pp. 973-979
dc.descriptionCallaghan, N., O'Hare, J., O'Driscoll, D., Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal) (1982) Dev Med Child Neurol, 24, pp. 830-836
dc.descriptionSato, S., White, B.G., Penry, J.K., Valproic acid versus ethosuximide in the treatment of absence seizures (1982) Neurology, 32, pp. 157-163
dc.descriptionMartinovic, Z., Comparison of ethosuximide with sodium valproate (1983) Advances in Epileptology, pp. 301-305. , Parsonage M. et al., eds. New York: XIVth Epilepsy International Symposium, Raven Press
dc.descriptionCoppola, G., Auricchio, G., Federico, R., Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: An open-label, randomized, parallel-group study (2004) Epilepsia, 45, pp. 1049-1053
dc.descriptionPosner, E.B., Mohamed, K., Marson, A.G., Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2003) Cochrane Database Syst Rev, pp. CD003032
dc.descriptionCallaghan, N., Odriscoll, D., Daley, M., A comparative study between ethosuximide and sodium valproate in the treatment of petit mal epilepsy (1980) Royal Society of Medicine International Congress and Symposium, No. 30: The Place of Sodium Valproate in the Treatment of Epilepsy, pp. 47-52. , London: Academic Press
dc.descriptionRating, D., Wolf, C., Bast, T., Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: A 6-month randomized, double-blind, placebo- controlled study: Sulthiame Study Group (2000) Epilepsia, 41, pp. 1284-1288
dc.descriptionMitsudome, A., Ohfu, M., Yasumoto, S., The effectiveness of clonazepam on the Rolandic discharges (1997) Brain Dev, 19, pp. 274-278
dc.descriptionBourgeois, B., Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): A 36-week, double-blind, placebo-controlled study (1998) Epilepsia, 39 (6 SUPPL.), p. 163
dc.descriptionMa, C.K., Chan, K.Y., Benign childhood epilepsy with centrotemporal spikes: A study of 50 Chinese children (2003) Brain Dev, 25, pp. 390-395
dc.descriptionDulac, O., Figueroa, D., Rey, E., Arthuis, M., Monotherapy with clobazam in epilepsies in children (1983) Presse Med, 12, pp. 1067-1069
dc.descriptionBarron, T.F., Hunt, S.L., Hoban, T.F., Price, M.L., Lamotrigine monotherapy in children (2000) Pediatr Neurol, 23, pp. 160-163
dc.descriptionBello-Espinosa, L.E., Roberts, S.L., Levetiracetam for benign epilepsy of childhood with centrotemporal spikes: Three cases (2003) Seizure, 12, pp. 157-159
dc.descriptionSundqvist, A., Tomson, T., Lundkvist, B., Valproate as monotherapy for juvenile myoclonic epilepsy: Dose-effect study (1998) Ther Drug Monit, 20, pp. 149-157
dc.descriptionSundqvist, A., Nilsson, B.Y., Tomson, T., Valproate monotherapy in juvenile myoclonic epilepsy: Dose-related effects on electroencephalographic and other neurophysiologic tests (1999) Ther Drug Monit, 21, pp. 91-96
dc.descriptionTimmings, P.R., A. Efficacy of lamotrigine as monotherapy for juvenile myoclonic epilepsy: Pilot study results in 20th IEC (1993) Epilepsia, 34 (2 SUPPL.), p. 160
dc.descriptionObeid, T., Panayiotopoulos, C.P., Clonazepam in juvenile myoclonic epilepsy (1989) Epilepsia, 30, pp. 603-606
dc.descriptionSmith, K.B., Pritchett, T., Levetiracetam, a promising option for the treatment of juvenile myoclonic epilepsy (2000) Epilepsia, 41, p. 39
dc.descriptionBuchanan, N., The use of lamotrigine in juvenile myoclonic epilepsy (1996) Seizure, 5, pp. 149-151
dc.descriptionCarrazana, E.J., Wheeler, S.D., Exacerbation of juvenile myoclonic epilepsy with lamotrigine (2001) Neurology, 56, pp. 1424-1425
dc.descriptionRosenfeld, W., Topiramate in patients with juvenile myoclonic epilepsy (1998) Epilepsia, 39 (6 SUPPL.), pp. S139
dc.descriptionMullin, P.S.J.M., Effectiveness of open-label zonisamide in juvenile myoclonic epilepsy (2001) Epilepsia, 42 (7 SUPPL.), p. 184
dc.descriptionAtakli, D., Sozuer, D., Atay, T., Misdiagnosis and treatment in juvenile myoclonic epilepsy (1998) Seizure, 7, pp. 63-66
dc.descriptionBourgeois, B., Monotherapy with VPA in primary generalized epilepsy (1987) Epilepsia, 28 (2 SUPPL.), pp. S8-S11
dc.descriptionDelgado-Escueta, A.V., Enrile-Bacsal, F., Juvenile myoclonic epilepsy of Janz (1984) Neurology, 34, pp. 285-294
dc.descriptionFernando-Dongas, M.C., Radtke, R.A., Vanlandingham, K.E., Husain, A.M., Characteristics of valproic acid resistant juvenile myoclonic epilepsy (2000) Seizure, 9, pp. 385-388
dc.descriptionJanz, D., Ruckfall: Prognose nach reduction der medikamente bei epilepsiebehandling (1983) Nervenarzt, 54, pp. 525-529
dc.descriptionKleveland, G., Engelsen, B.A., Juvenile myoclonic epilepsy: Clinical characteristics, treatment and prognosis in a Norwegian population of patients (1998) Seizure, 7, pp. 31-38
dc.descriptionPenry, J.K., Dean, J.C., Riela, A.R., Juvenile myoclonic epilepsy: Long-term response to therapy (1989) Epilepsia, 30 (4 SUPPL.), pp. S19-23
dc.descriptionSharpe, C., Buchanan, N., Juvenile myoclonic epilepsy: Diagnosis, management and outcome (1995) Med J Aust, 162, pp. 133-134
dc.descriptionBiraben, A., Allain, H., Scarabin, J.M., Exacerbation of juvenile myoclonic epilepsy with lamotrigine (2000) Neurology, 55, p. 1758
dc.languageen
dc.publisher
dc.relationEpilepsia
dc.rightsfechado
dc.sourceScopus
dc.titleIlae Treatment Guidelines: Evidence-based Analysis Of Antiepileptic Drug Efficacy And Effectiveness As Initial Monotherapy For Epileptic Seizures And Syndromes
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución